Walgreens partners with Verily to cut healthcare costs

Adjust Comment Print

Walgreens Boots Alliance has joined hands with Alphabet's life sciences unit Verily to improve the outcomes for individuals suffering from chronic conditions.

Other institutional investors and hedge funds have also modified their holdings of the company. The correct version of this story can be read at https://www.baseballdailydigest.com/news/2018/12/20/compagnie-lombard-odier-scma-has-1-39-million-stake-in-walgreens-boots-alliance-inc-wba.html. Asset Dedication LLC lifted its position in Walgreens Boots Alliance by 204.6% in the 3rd quarter.

Performance Evaluation of Walgreens Boots Alliance, Inc. This is something that investor look for in all the stocks in which investor is trading and this is an important indicator to keep tabs on. The stock generated performance of 2.82% tracking last 3 months and 7.78% over the recent 6 months.

WBA recently closed with fall of -14.26% to its twenty-Day SMA. Barclays increased their target price on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the stock an "equal weight" rating in a report on Friday, October 12th. The company was downgraded on Friday, June 29 by Robert W. Baird. - Nasdaq" on November 28, 2018, also Nasdaq.com with their article: "Mid-Morning Market Update: "Markets Mostly Lower; Walgreens Earnings Top Expectations - Nasdaq" published on December 20, 2018, Nasdaq.com published: "Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: "What You Should Know - Nasdaq" on November 22, 2018. The rating was maintained by Pivotal Research with "Hold" on Wednesday, June 27. More interesting news about Walgreens Boots Alliance, Inc. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and seven have assigned a buy rating to the company's stock. Meanwhile, the company keep the average true range (ATR) indicator of around about 2.39that is expressing range of a day's stock trading is high-low. The company's stock had a trading volume of 12,564,059 shares, compared to its average volume of 6,344,295. The stock was sold at an average price of $78.77, for a total value of $4,096,040.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Historical volatility is a quantifiable number which is based on past changes to the price of a stock or futures contract. The stock has a consensus rating of "Hold" and an average price target of $79.11. The disclosure for this sale can be found here. Insiders have sold a total of 73,756 shares of company stock worth $5,824,194 in the last three months. Company insiders own 15.73% of the company's stock.

WBA opened at $69.61 on Friday. The company has a quick ratio of 0.38, a current ratio of 0.82 and a debt-to-equity ratio of 0.47.

More notable recent Walgreens Boots Alliance, Inc. Commonly referred to as "market cap", it is calculated by multiplying a company's shares outstanding by the current market price of one share.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, December 20th. The pharmacy operator reported $1.48 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%.

Sales rose 9.9% to $33.79 billion, better than analysts expected, helped partially by a sales boost from the stores that Walgreens acquired from Rite Aid. Traders to this company got a return of 7.30% on the assets it owns in past 1 Year. The business's revenue was up 9.9% compared to the same quarter past year.

During the first quarter, the company declared a regular quarterly dividend of $0.44 per share. Investors of record on Monday, November 12th were paid a dividend of $0.44 per share.